Circulating Tumor Cells 2013

The rapid expansion in the use of circulating tumor cells (CTCs) as a diagnostic tool and a biomarker will provide a much needed tool in the treatment of cancer.  The use of CTCs provides a non-invasive means of gaining early insight into tumor detection and metastasis, and has become an indispensable tool for patient management and oncology drug development. This conference dedicated to CTCs will cover a range of aspects concerning CTCs’ origin, biology, characterization, enumeration and subsequent analysis.  The conference will also highlight approaches to technology development that include the use of microfluidics for cell enumeration, and case studies on the clinical use of CTCs for guiding the selection of therapy and monitoring response.  This meeting will bring you up to date on the state-of-the-art tools and what is needed to make these technologies robust and ready for use by the clinical community.

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as  R&D, Oncology, Cell Biology, Chemistry and Biotechnology.